Topic: Disease

Technologies Developed in Texas Help Make the 'Engineering' of Complex Tissues and Organs Feasible

Nov. 6, 2012

In this talk, Dr. Doris A. Taylor will discuss the discovery and application of new knowledge and technologies to improve patient care and to prevent cardiovascular disease. She will share how building new cell- and organ-based solutions for severe diseases could affect millions of patients who suffer from or who are at risk for these diseases. Taylor is working to "engineer" cardiac muscle, valves and vasculature, with many of these technologies now progressing to first-in-human use trials.

Read more

Developing New Vaccines for Emerging Diseases is Focus of $6.5 Million Contract

Oct. 22, 2012

Accelerating the evaluation and development of new vaccines for emerging health threats is the goal of University of Texas at Austin researchers who recently received $6.5 million from the U.S. Department of Defense and the Defense Threat Reduction Agency.

Read more

Drug Design, Environmental Sustainability, Oil Recovery Receive Private Grand Challenge Research Funds

May 4, 2011

Seven University of Texas at Austin researchers are confronting what the scientific community has defined as this century's grand challenges in drug design, environmental sustainability and improved oil recovery using Moncrief Grand Challenge Faculty awards for 2011-12.

Read more

Historian joins Bill Gates' anti-polio efforts

Jan. 27, 2011
History Professor David Oshinsky won the 2006 Pulitzer Prize for his book "Polio: An American Story."

Watch a Jan. 31 live stream of Pulitzer-winning Professor David Oshinsky and Gates Foundation guests discussing eradication of the disease.

Read more

Research of Cell Movements in Developing Frogs Reveals New Twists in Human Genetic Disease

July 30, 2010

Mutations in a gene known as "Fritz" may be responsible for causing human genetic disorders such as Bardet-Biedl syndrome, University of Texas at Austin developmental biologist John Wallingford and Duke University human geneticist and cell biologist Nicholas Katsanis have found.

Read more